Results: 11
Patient Organizations' Barriers in Pharmacovigilance and Strategies to Stimulate Their Participation.
- Published in:
- Drug Safety, 2021, v. 44, n. 2, p. 181, doi. 10.1007/s40264-020-00999-0
- By:
- Publication type:
- Article
A Comparative View of Reported Adverse Effects of Statins in Social Media, Regulatory Data, Drug Information Databases and Systematic Reviews.
- Published in:
- Drug Safety, 2021, v. 44, n. 2, p. 167, doi. 10.1007/s40264-020-00998-1
- By:
- Publication type:
- Article
Correction to: A Comparative View of Reported Adverse Effects of Statins in Social Media, Regulatory Data, Drug Information Databases and Systematic Reviews.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer.
- Published in:
- Drug Safety, 2021, v. 44, n. 2, p. 245, doi. 10.1007/s40264-020-01015-1
- By:
- Publication type:
- Article
Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Real-World Data on Nonmedical Use of Tramadol from Patients Evaluated for Substance Abuse Treatment in the NAVIPPRO Addiction Severity Index-Multimedia Version (ASI-MV<sup>®</sup>) Network.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Patient-Reported Adverse Events of Radiopharmaceuticals: A Prospective Study of 1002 Patients.
- Published in:
- Drug Safety, 2021, v. 44, n. 2, p. 211, doi. 10.1007/s40264-020-01006-2
- By:
- Publication type:
- Article
Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment Using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Artificial Intelligence, Real-World Automation and the Safety of Medicines.
- Published in:
- Drug Safety, 2021, v. 44, n. 2, p. 125, doi. 10.1007/s40264-020-01001-7
- By:
- Publication type:
- Article
Adverse Drug Reaction Reporting Using a Mobile Device Application by Persons with Multiple Sclerosis: A Cluster Randomized Controlled Trial.
- Published in:
- Drug Safety, 2021, v. 44, n. 2, p. 223, doi. 10.1007/s40264-020-01009-z
- By:
- Publication type:
- Article